ADAM8 in squamous cell carcinoma of the head and neck: A retrospective study

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Zielinski, Valerie ^a   Brunner, Markus ^a   Heiduschka, Gregor ^a   Schneider, Sven ^a   Seemann, Rudolf ^a   Erovic, Boban ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ADAM8; Head and neck; Squamous cell carcinoma

Indexed keywords

ADAM PROTEIN; ADAM8 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TISSUE MICROARRAY;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MICROARRAY ANALYSIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84857392594     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-76     Document Type: Article

References (13)

1. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008, 359(11):1143-1154. 10.1056/NEJMra0707975, 18784104.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
3. Lowy DR, Munger K. Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med 2010, 363(1):82-84. 10.1056/NEJMe1003607, 20530315.
4. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007, 98(5):621-628. 10.1111/j.1349-7006.2007.00434.x, 17355265.
5. Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet 2000, 16(2):83-87. 10.1016/S0168-9525(99)01926-5, 10652535.
6. Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G. ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis. Virchows Arch 2006, 449(6):628-636. 10.1007/s00428-006-0315-1, 17106710.
7. Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J Cell Mol Med 2007, 11(5):1162-1174. 10.1111/j.1582-4934.2007.00082.x, 17979891.
8. Werner JA, Rathcke IO, Mandic R. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002, 19(4):275-282. 10.1023/A:1015531319087, 12090467.
9. Abela JR, Parkinson C, Stolow D, Starrs C. A test of the integration of the hopelessness and response styles theories of depression in middle adolescence. J Clin Child Adolesc Psychol 2009, 38(3):354-364. 10.1080/15374410902851630, 19437296.
10. Wildeboer D, Naus S, Amy Sang QX, Bartsch JW, Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol 2006, 65(5):516-527. 10.1097/01.jnen.0000229240.51490.d3, 16772875.
11. Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y. ADAM8 as a novel serological and histochemical marker for lung cancer. Clin Cancer Res 2004, 10(24):8363-8370. 10.1158/1078-0432.CCR-04-1436, 15623614.
12. Moye LA. Alpha calculus in clinical trials: considerations and commentary for the new millennium. Stat Med 2000, 19(6):767-779. 10.1002/(SICI)1097-0258(20000330)19:6<767::AID-SIM518>3.0.CO;2-U, 10734280.
13. Stokes A, Joutsa J, Ala-Aho R, Pitchers M, Pennington CJ, Martin C, Premachandra DJ, Okada Y, Peltonen J, Grenman R, et al. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res 2010, 16(7):2022-2035. 10.1158/1078-0432.CCR-09-2525, 20305301.